SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SPAGO Nanomedical AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10582
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of soft tissue tumors and metastases; and tumorad, a nanomedical therapeutic agent loaded with radioactive isotopes in order to enable internal tumor selective radiotherapy. It uses its internally developed technologies as therapeutics, diagnostics, theranostics and drug delivery agents. The company caters to pharmaceutical industry for discovery research, early clinical application and business development. Spago Nanomedical is headquartered in Lund, Sweden.

SPAGO Nanomedical AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SPAGO Nanomedical AB, Medical Devices Deals, 2012 to YTD 2018 9
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
SPAGO Nanomedical Raises USD1 Million in Private Placement of Shares 11
Equity Offering 12
SPAGO Nanomedical Raises USD5.9 Million in Rights Offering of Shares 12
Spago Nanomedical Raises USD3 Million in Rights Issue of Shares 13
SPAGO Nanomedical AB – Key Competitors 14
SPAGO Nanomedical AB – Key Employees 15
SPAGO Nanomedical AB – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Mar 22, 2017: Anna Sundlov Nominated to the Board of Directors in Spago Nanomedical 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Key Facts 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SPAGO Nanomedical AB, Deals By Therapy Area, 2012 to YTD 2018 8
SPAGO Nanomedical AB, Medical Devices Deals, 2012 to YTD 2018 9
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SPAGO Nanomedical Raises USD1 Million in Private Placement of Shares 11
SPAGO Nanomedical Raises USD5.9 Million in Rights Offering of Shares 12
Spago Nanomedical Raises USD3 Million in Rights Issue of Shares 13
SPAGO Nanomedical AB, Key Competitors 14
SPAGO Nanomedical AB, Key Employees 15

List of Figures
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SPAGO Nanomedical AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Hain Celestial Group, Inc.:戦略・SWOT・企業財務分析
    The Hain Celestial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hain Celestial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Lenovo Group Limited:企業の戦略・SWOT・財務分析
    Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report Summary Lenovo Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Orbis Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Orbis Biosciences Inc (Orbis) is a developer of pharmaceutical products that offers optimizes oral and injectable products. The company provides preclnical pipeline indications for pathologies including cancer, bronchiolitis, Eczema, atopic dermatitis, nephrotic syndrome, HIV, asthma, bunine …
  • Hollister Inc:企業の戦略的SWOT分析
    Hollister Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Pampa Energia S.A (PAMP)-石油・ガス分野:企業M&A・提携分析
    Summary Pampa Energia S.A. (Pampa) is an integrated energy company. It generates, transmits and distributes electricity. The company produces electricity from thermal, hydro and wind sources. Pampa explores for and produces hydrocarbon products in Argentina, Ecuador and Venezuela; refines diesel, fu …
  • WorleyParsons Limited:企業の戦略・SWOT・財務情報
    WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report Summary WorleyParsons Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Angelini Group:企業の戦略的SWOT分析
    Angelini Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • South Egypt Drug Industries Co:企業の戦略的SWOT分析
    South Egypt Drug Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Korean Reinsurance Company:企業の戦略・SWOT・財務情報
    Korean Reinsurance Company - Strategy, SWOT and Corporate Finance Report Summary Korean Reinsurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nanoco Group Plc (NANO):企業の財務・戦略的SWOT分析
    Nanoco Group Plc (NANO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Browns Brasserie and Bar:企業の戦略・SWOT・財務情報
    Browns Brasserie and Bar - Strategy, SWOT and Corporate Finance Report Summary Browns Brasserie and Bar - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Molex LLC:企業の戦略的SWOT分析
    Molex LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • ALTANA AG:戦略・SWOT・企業財務分析
    ALTANA AG - Strategy, SWOT and Corporate Finance Report Summary ALTANA AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • ITT Inc (ITT):企業の財務・戦略的SWOT分析
    ITT Inc (ITT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Vulcan Materials Company:企業の戦略・SWOT・財務分析
    Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report Summary Vulcan Materials Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • HITT Contracting Inc:企業の戦略的SWOT分析
    HITT Contracting Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Caretech Holdings Plc (CTH):企業の財務・戦略的SWOT分析
    Summary Caretech Holdings Plc (CareTech) is a children and adult care service provider. The company offers solution for adults and solution for children and young people. its adult care services includes learning disability, mental health, acquired brain injury, eating disorders, sensory impairments …
  • Merz Pharma GmbH & Co. KGaA:企業のM&A・事業提携・投資動向
    Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merz Pharma GmbH & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Known as Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary p …
  • Iridium Communications Inc (IRDM):企業の財務・戦略的SWOT分析
    Iridium Communications Inc (IRDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆